China Healthwise Holdings Limited (0348.HK)
HKSE · HKD · Healthcare · Pharmaceutical Retailers
HK$0.073 (-1.35%) as of
Key statistics
- Market cap
- 67.49M
- EPS (TTM)
- -0.040
- Dividend yield
- 0.00%
- 52-week range
- 0.051 – 0.220
- Beta
- -0.50
- Revenue (TTM)
- 84.97M
- Profit margin
- -38.98%
- Volume
- 90.00k
About China Healthwise Holdings Limited
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand name. It is also involved in money lending business; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Central, Hong Kong
- Employees
- 70
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.